BSE Live
Dec 31, 16:01Prev. Close
1104.65
Open Price
1110.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 15 | |
| Per Share Ratios | ||
| Basic EPS (Rs.) | 2.08 | |
| Diluted EPS (Rs.) | 2.08 | |
| Cash EPS (Rs.) | 4.78 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 43.28 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 43.28 | |
| Revenue from Operations/Share (Rs.) | 118.83 | |
| PBDIT/Share (Rs.) | 8.34 | |
| PBIT/Share (Rs.) | 5.38 | |
| PBT/Share (Rs.) | 3.06 | |
| Net Profit/Share (Rs.) | 1.82 | |
| NP After MI And SOA / Share (Rs.) | 2.08 | |
| Profitability Ratios | ||
| PBDIT Margin (%) | 7.02 | |
| PBIT Margin (%) | 4.53 | |
| PBT Margin (%) | 2.57 | |
| Net Profit Margin (%) | 1.53 | |
| NP After MI And SOA Margin (%) | 1.74 | |
| Return on Networth/Equity (%) | 4.76 | |
| Return on Capital Employed (%) | 11.91 | |
| Return on Assets (%) | 2.45 | |
| Total Debt/Equity (X) | 0.39 | |
| Asset Turnover Ratio (%) | 140.34 | |
| Liquidity Ratios | ||
| Current Ratio (X) | 1.40 | |
| Quick Ratio (X) | 1.03 | |
| Inventory Turnover Ratio (X) | 8.11 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | |
| Coverage Ratios | ||
| Interest Coverage Ratios (%) | 2.31 | |
| Interest Coverage Ratios (Post Tax) (%) | 2.31 | |
| Valuation Ratios | ||
| Enterprise Value (Cr.) | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | |
| EV/EBITDA (X) | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | |
| Retention Ratios (%) | 0.00 | |
| Price/BV (X) | 0.00 | |
| Price/Net Operating Revenue | 0.00 | |
| Earnings Yield | 0.00 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y